Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013 (2013), Article ID 951343, 10 pages
http://dx.doi.org/10.1155/2013/951343
Research Article

Gene Therapy with HSV1-sr39TK/GCV Exhibits a Stronger Therapeutic Efficacy Than HSV1-TK/GCV in Rat C6 Glioma Cells

1Department of Intensive Care Unit, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China
2Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040, China
3Department of Neurology, the Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China
4Department of Nuclear Medicine, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China
5Department of Neurosurgery, the First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China
6Department of Neurosurgery, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China

Received 5 January 2013; Accepted 29 January 2013

Academic Editors: W. Hall, D. Morris, and G. P. Siegal

Copyright © 2013 Lei-qing Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Lei-qing Li, Fang Shen, Xiao-yan Xu, Hong Zhang, Xiao-feng Yang, and Wei-guo Liu, “Gene Therapy with HSV1-sr39TK/GCV Exhibits a Stronger Therapeutic Efficacy Than HSV1-TK/GCV in Rat C6 Glioma Cells,” The Scientific World Journal, vol. 2013, Article ID 951343, 10 pages, 2013. doi:10.1155/2013/951343